Einloggen

Thematische Bibliographien / Hepatitis C / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Hepatitis C.

Zeitschriftenartikel zum Thema „Hepatitis C“

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 25. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Hepatitis C" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Der volle Inhalt der Quelle

Annotation:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Jamali, Ghulam Mustafa, Anwar Ali Jamali, and Habibullah Shaikh. "HEPATITIS C VIRUS;." Professional Medical Journal 24, no. 11 (2017): 1621–29. http://dx.doi.org/10.29309/tpmj/2017.24.11.646.

Der volle Inhalt der Quelle

Annotation:

Objectives: The plan of this current research was in the direction for towards theassessment of the existing ELISA (Enzyme Linked Immunosorbant Assay) method throughantibodies testing for identification of hepatitis C virus disease by comparing their outcome withthe Real Time polymerase chain reaction analysis. Setting: Peoples Medical College HospitalNawabshah. Period: December 2015 to December 2016. Methods: In this current research 100blood samples were analyzed due to the presence of anti-HCV antibodies by 3rd-generationenzyme-linked immunosorbent assay testing. All the specimens were 100%

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

TARIQ, FAQIR MUHAMMAD, IRSHAD AHMAD, HABIB SUBHANI, and Irshad Ul Haq. "HEPATITIS C." Professional Medical Journal 16, no. 02 (2009): 169–72. http://dx.doi.org/10.29309/tpmj/2009.16.02.2890.

Der volle Inhalt der Quelle

Annotation:

I n t r o d u c t i o n : Hepatitis C is a RNA virus isolated in 1988 but still not cultured in the laboratory. Hepatitis-C infection is aserious global public health issue, WHO estimates worlds 3 % population is HCV positive. Pakistan is also facing the huge burden of thisdisease. Accurate prevalence information for hepatitis C infection is scant in Pakistan. Few population based studies are available, the mostcomprehensive being that of Luby et al which after testing a representative sample from a population of 150,000 in Hafizabad, Pakistanfound an overall sero-prevalence of 6%. This increa

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Der volle Inhalt der Quelle

Annotation:

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Der volle Inhalt der Quelle

Annotation:

Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Der volle Inhalt der Quelle

Annotation:

INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Vijendra, Singh Rawat, Ranjan Neelima, Jain Isha, and Bharat Jain Savita. "Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein." International Journal of Pharmaceutical and Clinical Research 15, no. 6 (2023): 2003–8. https://doi.org/10.5281/zenodo.12529982.

Der volle Inhalt der Quelle

Annotation:

<strong>Background: </strong>Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. <strong>Materials and Methods: </strong>Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. <strong>Results:</strong> The seroprevalence of HBV and HCV in our study sam

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Andrade, Luís Jesuino, Paulo Melo, Isabel Lins, Raymundo Paraná, and Augusto Lins. "HEPATITIS C VIRUS AND HEPATITIS C-INFECTION." Brazilian Journal of Medicine and Human Health 3, no. 1 (2015): 19–28. http://dx.doi.org/10.17267/2317-3386bjmhh.v3i1.453.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Moradpour and Blum. "Hepatitis C." Therapeutische Umschau 61, no. 8 (2004): 493–98. http://dx.doi.org/10.1024/0040-5930.61.8.493.

Der volle Inhalt der Quelle

Annotation:

Die Infektion mit dem Hepatitis C Virus (HCV) ist weltweit eine der häufigsten Ursachen der chronischen Hepatitis, Leberzirrhose und des hepatozellulären Karzinoms. In diesem Beitrag werden der aktuelle Stand und neue Entwicklungen auf dem Gebiet der Virologie, Diagnostik und Therapie der Hepatitis C zusammenfassend dargestellt. Die Standardtherapie der chronischen Hepatitis C mit pegyliertem Interferon-alpha und Ribavirin führt bei etwa 40–50% der Genotyp 1- und rund 80% der Genotyp 2 und 3-infizierten Patienten zur anhaltenden Viruselimination. Aufbauend auf einem verbesserten Verständnis de

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Khan, Momin, Abdul Jabbar, Bacha Amin Khan, Abdul Ahad, and Fazal Akbar. "HEPATITIS C." Professional Medical Journal 25, no. 04 (2018): 484–88. http://dx.doi.org/10.29309/tpmj/2018.25.04.332.

Der volle Inhalt der Quelle

Annotation:

Introduction: WHO estimates that there are more than 185 million people overthe globe infected with hepatitis C. Among these 350,000 die each year with hepatitis. Heprevalence of hepatitis in Asia is estimated to be 3.4%. Pakistan has been rated as the secondmost common country in the world with active hepatitis C infection. This study aims at identifyingthe frequency of risk factors for hepatitis C irus transmission. Understanding the frequency ofcommon factors of HCV would help to implement strategies in long-term prevention of hepatitistransmission among community. Objectives: To determine

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Calmet Schwartzmann, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2018): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.119.

Der volle Inhalt der Quelle

Annotation:

El virus de la hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis Ay B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis "no A, no B". No fue hasta 1989 que se aisló el VHC por primera vez y entre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Calmet Schwartzmamn, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2020): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.166.

Der volle Inhalt der Quelle

Annotation:

El virus de hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis A y B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis ''no A, no B''. No fue hasta 1989 que se aisló el VHC por primera vez y emtre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Icole, F., J. P. Bronowicki, C. Jeannoel, P. Besancon, and F. Boulanger. "Screening for hepatitis C in psychiatric population." European Psychiatry 64, S1 (2021): S90—S91. http://dx.doi.org/10.1192/j.eurpsy.2021.267.

Der volle Inhalt der Quelle

Annotation:

IntroductionA meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conducted to determine seroprevalence of hepatitis C in population admitted in psychiatric institution.ObjectivesThe aims of this study are to determine seroprevalence of hepatitis C in population admitted in psychiatric institution and describe the profile of infected patients.MethodsFrom january 2020 to o

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar, and Abdul Rashid. "HEPATITIS B AND C." Professional Medical Journal 22, no. 11 (2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Der volle Inhalt der Quelle

Annotation:

Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hosp

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Ball, Lynda K., and Jan Riordan. "Hepatitis C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.2307/3522172.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Rajan-Mohandas, N. "Hepatitis C." Pediatrics in Review 20, no. 9 (1999): 323. http://dx.doi.org/10.1542/pir.20-9-323.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Jou, Janice H., and Andrew J. Muir. "Hepatitis C." Annals of Internal Medicine 148, no. 11 (2008): ITC6–1. http://dx.doi.org/10.7326/0003-4819-148-11-200806030-01006.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Birmingham, Karen. "Hepatitis C." Inpharma Weekly &NA;, no. 1150 (1998): 3–4. http://dx.doi.org/10.2165/00128413-199811500-00003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Jou, Janice H., and Andrew J. Muir. "Hepatitis C." Annals of Internal Medicine 157, no. 11 (2012): ITC6–1. http://dx.doi.org/10.7326/0003-4819-157-11-201212040-01006.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C;." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/18.4065.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Khan, Momin, Abdul Jabbar, Bacha Amin Khan, Abdul Ahad, and Fazal Akbar. "HEPATITIS C;." Professional Medical Journal 25, no. 04 (2018): 484–88. http://dx.doi.org/10.29309/tpmj/18.4293.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Iqbal, Sajjad, Khalil-Ur Rahman, Muhammad Haroon Yousuf, and Nazish Jahan. "HEPATITIS C." Professional Medical Journal 22, no. 04 (2015): 432–38. http://dx.doi.org/10.29309/tpmj/2015.22.04.1321.

Der volle Inhalt der Quelle

Annotation:

Hepatitis C virus (HCV) has infected about 200 million individuals across theworld and is known as the major cause of liver disease . Objectives: Viral load measurementat early stages of the therapy in Hepatitis C patients is believed to be a more effective toolto predict the sustained virological response (SVR). The primary aim of the present studywas to evaluate whether the decline in viral load of HCV at early stages of the therapy maypredict the treatment response. Another objective was to see the benefits of therapy extensionin non-responders. Study Design: Descriptive, analytical study.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

KITCHLEW, RIZWANA, FUAD AHMAD SIDDIQI, and ASIF HASHMI. "HEPATITIS C;." Professional Medical Journal 19, no. 03 (2012): 375–81. http://dx.doi.org/10.29309/tpmj/2012.19.03.2149.

Der volle Inhalt der Quelle

Annotation:

Background: Liver biopsy the gold standard for the histological assessment in chronic hepatitis C is an invasive procedure withcertain limitations. Objective: It was to evaluate the relation of serum ALT levels with the histological changes in healthy blood donors screenedpositive for HCV. Study Design: This cross sectional comparative study Setting: It was conducted at department of medicine CombinedMilitary Hospital Lahore, from January to August 2004 Method: 76 apparently healthy blood donor soldiers age 20 – 49 years positive for HCVantibodies by third generation ELISA test, evaluated by m

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

AHMED, WAHEED, SYED BADSHAH HUSSAIN ZAIDI, and MANZAR ZAKARIA. "HEPATITIS C." Professional Medical Journal 17, no. 01 (2010): 117–21. http://dx.doi.org/10.29309/tpmj/2010.17.01.2087.

Der volle Inhalt der Quelle

Annotation:

Objectives: To determine the frequency of thrombocytopenia and its manifestations in patients with Chronic Hepatitis C Virusinfection treated with interferon and ribavirin. Data Source: In door and out door patients. Design of Study: Case series. Setting and Periodof Study: Department of Medicine PNS Shifa Hospital Karachi, from 1s t August 2006 to 1s t July 2007. Materials and Methods: A Proformawas designed to enter the data of 100 patients fulfilling the inclusion criteria included in the study. Adult patients between the ages of 18 and50 years of both gender were selected. Presence of anti

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

MEHMOOD KHAN, MUZAFFAR, Muhammad TAHIR, Mohsin RAZA, Muhammad Ali BHATTI, and Muhammad Riaz Khokar. "HEPATITIS ‘C’;." Professional Medical Journal 19, no. 02 (2012): 193–96. http://dx.doi.org/10.29309/tpmj/2012.19.02.2007.

Der volle Inhalt der Quelle

Annotation:

Objective: The objective of this study was to determine association of Interferon-Ribavarin therapy with hearing loss in patientssuffering from Hepatitis ‘C’. Study Design: Quasi-experimental study. Place and Duration: Otolaryngology Department Combined MilitaryHospital Rawalpindi from 09 June 2006 to 08 June 2007. Patients and Methods: Consenting sixty patients of Hepatitis C divided into two equalgroups of 30 each, (group A receiving Interferon-Ribavarin therapy and group B, not receiving it) during the study period fitting the inclusioncriteria were selected. Pure Tone Audiometery including

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

CHAUDRY, NAYLA TARIQ, IMRANA IHSAN, WAHEED JAMEEL, and Sabiha Nasreen. "HEPATITIS - C." Professional Medical Journal 12, no. 04 (2005): 364–67. http://dx.doi.org/10.29309/tpmj/2005.12.04.5082.

Der volle Inhalt der Quelle

Annotation:

Objectives: 1) To evaluate the overall prevalence rate of viral hepatitiscarrier state among a group of voluntary blood donors. 2) To find the proportion of anti HCV in the study group. 3) Tofind the probable mode of transmission of HCV infection in the study group. Setting: Pathology lab, Jinnah Hospital,Iqra Medical Complex & Hi Tech Lab, Lahore. Period: November 2000 to April 2001. Patients & Methods: A total of890 apparently healthy blood donors (797 males, 93 females) were studied. Clinical details were recorded. The bloodsamples were collected using packed sterile disposable syri

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Rajan-Mohandas, Niranjana. "Hepatitis C." Pediatrics In Review 20, no. 9 (1999): 323. http://dx.doi.org/10.1542/pir.20.9.323.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Eames, Jennifer R., and Bau Tran. "Hepatitis C." Physician Assistant Clinics 6, no. 4 (2021): 555–68. http://dx.doi.org/10.1016/j.cpha.2021.05.002.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Foster, Graham. "Hepatitis C." Drugs in Context 4 (2007): 1. http://dx.doi.org/10.7573/dic.212201.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Wong, John B. "Hepatitis C." PharmacoEconomics 24, no. 7 (2006): 661–72. http://dx.doi.org/10.2165/00019053-200624070-00005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Malpas, Michael. "Hepatitis C." Nursing Standard 25, no. 37 (2011): 59. http://dx.doi.org/10.7748/ns2011.05.25.37.59.c8522.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Dawson, Stacey, and Emma Meader. "Hepatitis C." InnovAiT: Education and inspiration for general practice 11, no. 2 (2018): 101–8. http://dx.doi.org/10.1177/1755738017740161.

Der volle Inhalt der Quelle

Annotation:

Hepatitis C virus (HCV) infection affects approximately 180 000 000 people worldwide, with the highest rates reported in Africa and Asia. In the UK, the rate is in the region of 1% of the population. Most infections become chronic and can lead to extensive liver damage and hepatocellular carcinoma. Despite recent advances in treatment strategies the high cost, high demand, screening uptake and re-infection rates make HCV one of the greatest healthcare challenges of modern medicine. This article provides an overview of HCV and aims to equip GPs for their role in screening and management in prim

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Hepworth, Julie, and Gary J. Krug. "Hepatitis C." Journal of Health Psychology 4, no. 2 (1999): 237–46. http://dx.doi.org/10.1177/135910539900400216.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Belville-Robertson, T. L., L. R. Clemensen, and A. K. Eshelman. "HEPATITIS C." Psychosomatic Medicine 61, no. 1 (1999): 87. http://dx.doi.org/10.1097/00006842-199901000-00031.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Lavanchy, Daniel, and Pilar Gavinio. "Hepatitis C." Canadian Journal of Gastroenterology 14, suppl b (2000): 67B—77B. http://dx.doi.org/10.1155/2000/630301.

Der volle Inhalt der Quelle

Annotation:

Hepatitis C has been identified as the most common cause of post-transfusion hepatitis worldwide, accounting for approximately 90% of this disease in Japan, the United States and Western Europe. Hepatitis C is a major global public health problem. New infections continue to occur, and the source of infection includes transfusion of blood or blood products from unscreened donors; transfusion of blood products that have not undergone viral inactivation; parenteral exposure to blood through use of contaminated and inadequately sterilized instruments and needles used in medical, dental and ‘tradit

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Halsey, NA. "Hepatitis C." Nurse Practitioner 23, no. 6 (1998): 148. http://dx.doi.org/10.1097/00006205-199806000-00021.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Jenny-Avital, Elizabeth R. "Hepatitis C." Current Opinion in Infectious Diseases 11, no. 3 (1998): 293–300. http://dx.doi.org/10.1097/00001432-199806000-00005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Walsh, Kieran. "Hepatitis C." BMJ 328, no. 7451 (2004): 1296. http://dx.doi.org/10.1136/bmj.328.7451.1296.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Sarbah, Steedman A., and Zobair M. Younossi. "Hepatitis C." Journal of Clinical Gastroenterology 30, no. 2 (2000): 125–43. http://dx.doi.org/10.1097/00004836-200003000-00005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Zweben, Joan E. "Hepatitis C." Journal of Addictive Diseases 20, no. 1 (2001): 33–42. http://dx.doi.org/10.1300/j069v20n01_04.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Moore, Grace A., Diane A. Hawley, and Pat Bradley. "Hepatitis C." Gastroenterology Nursing 32, no. 2 (2009): 94–104. http://dx.doi.org/10.1097/sga.0b013e31819de48b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Burra, Patrizia. "Hepatitis C." Seminars in Liver Disease 29, no. 01 (2009): 053–65. http://dx.doi.org/10.1055/s-0029-1192055.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

PARINI, SUE. "Hepatitis C." Nursing 33, no. 4 (2003): 57–64. http://dx.doi.org/10.1097/00152193-200304000-00040.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Dusheiko, Geoffrey. "Hepatitis C." Medicine 30, no. 11 (2002): 37–40. http://dx.doi.org/10.1383/medc.30.11.37.28454.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Ball, Lynda K. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Riordan, Jan. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00004.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Bockhold, Kathleen. "HEPATITIS C." American Journal of Nursing 100, no. 12 (2000): 13. http://dx.doi.org/10.1097/00000446-200012000-00005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Marengo-Rowe, Alain J. "Hepatitis C." Baylor University Medical Center Proceedings 3, no. 4 (1990): 3–12. http://dx.doi.org/10.1080/08998280.1990.11929728.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!